Evaluation of the impact of serogroup C meningococcal disease vaccination program in Brazil and its regions: a population-based study, 2001-2013

Moraes, Camile de; Moraes, José Cássio de; Silva, Gabriela Drummond Marques da; Duarte, Elisabeth Carmen.
Mem. Inst. Oswaldo Cruz ; 112(4): 237-246, Apr. 2017. tab, graf
Artigo em Inglês | LILACS | ID: biblio-841785

Documentos relacionados

  1. Informing the use of a supplementary immunisation programme for the management of a community cluster of invasive meningococcal disease, Yorkshire, 2022.
  2. Effectiveness of a Meningococcal Group B Vaccine (4CMenB) in Children.
  3. Analysis of meningococcal vaccine uptake in patients with invasive meningococcal disease, Czech Republic, 2006-2022.
  4. Impact of Meningococcal ACWY Vaccination Program during 2017-18 Epidemic, Western Australia, Australia.
  5. Pediatric Invasive Meningococcal Disease, Auckland, New Zealand (Aotearoa), 2004-2020.
  6. B Part of It School Leaver Study: A Repeat Cross-Sectional Study to Assess the Impact of Increasing Coverage With Meningococcal B (4CMenB) Vaccine on Carriage of Neisseria meningitidis.
  7. Effectiveness of Meningococcal Vaccines at Reducing Invasive Meningococcal Disease and Pharyngeal Neisseria meningitidis Carriage: A Systematic Review and Meta-analysis.
  8. Systematic review of invasive meningococcal disease epidemiology in the Eastern Mediterranean and North Africa region.
  9. Global estimate of Neisseria meningitidis serogroups proportion in invasive meningococcal disease: A systematic review and meta-analysis.
  10. Risk of sequelae after invasive meningococcal disease.